MS
Morgan Stanley
MS has the edge over RNR overall, supported by stronger modeled upside and lower modeled downside.
RNR
RenaissanceRe Holdings Ltd.
RNR trails on the overall score without a compensating advantage in the available component scores.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
RNR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Strong | |
| N/A | |
| N/A |
RNR's profitability is currently strong, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like RNR.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over RNR in the historical PE scenario, which offers more potential upside but is not a forecast.
RNR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5x | $171 | -52% |
| Fair | 7.4x | $256 | -28% |
| Forward | 8.4x | $355 | — |
| Current | 10x | $355 | — |
| Expensive | 15x | $500 | +41% |
Historical ranges are pointers, not guarantees.
RNR's PE is in its fair range at 10x. On analysts' estimates for next year's earnings, today's price would be 8.4x.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over RNR on the outlook, with more favorable earnings and revenue expectations.
RNR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RNR's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over RNR on earnings, with more consistent year-over-year improvement.
RNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $42.22 | +22% |
| Q3 2026 | $34.47 | -4.5% |
| Q2 2026 | $57.88 | +47% |
| Q1 2026 | $59.33 | +88% |
| Q4 2025 | $56.03 | +59% |
| Q3 2025 | $36.11 | -49% |
| Q2 2025 | $39.33 | -24% |
| Q1 2025 | $31.54 | -32% |
| Q4 2024 | $35.21 | -33% |
RNR's earnings per share have fallen from their peak: $34.47 over the past year, against $70.44 in late 2024.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over RNR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over RNR on profitability, with a higher operating margin.
RNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | -47% |
| Q2 2026 | $2.8B | -14% |
| Q1 2026 | $2.2B | -37% |
| Q4 2025 | $3B | +30% |
| Q3 2025 | $3.2B | -20% |
| Q2 2025 | $3.2B | +13% |
| Q1 2025 | $3.5B | +34% |
| Q4 2024 | $2.3B | -29% |
RNR's revenue has slid since its 2024 peak: $1.7B last quarter, down 47% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.9% | -48 points |
| Q2 2026 | 40% | -1.4 points |
| Q1 2026 | 25% | +27 points |
| Q4 2025 | 43% | +46 points |
| Q3 2025 | 46% | +2.6 points |
| Q2 2025 | 42% | +17 points |
| Q1 2025 | -2% | -26 points |
| Q4 2024 | -3.6% | -48 points |
RNR's operating margin was −1.9% last quarter, down 48 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
RNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $794.5M | -50% |
| Q2 2026 | $852.4M | -42% |
| Q1 2026 | $687.6M | +336% |
| Q4 2025 | $483M | -38% |
| Q3 2025 | $1.6B | +6.2% |
| Q2 2025 | $1.5B | +21% |
| Q1 2025 | $157.8M | -77% |
| Q4 2024 | $778.9M | +52% |
RNR has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
RNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3% | -1.3M shares |
| 1 year | -12% | -5.7M shares |
| 3 years | -20% | -10.1M shares |
| 5 years | -13% | -5.9M shares |
| Available history | -7.5% | -3.3M shares |
RNR has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $310.1M |
| Q2 2026 | $350.5M |
| Q1 2026 | $352M |
| Q4 2025 | $660M |
| Q3 2025 | $208.3M |
| Q2 2025 | $373.6M |
| Q1 2025 | $357.7M |
| Q4 2024 | $451.6M |
RNR spent $1.7B buying back its own shares over the past year, up 20% from the year before.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
RNR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.1x | Very low |
RNR has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
RNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.5 | Neutral |
| Stochastic | 66.9 | Neutral |
RNR's weekly RSI is 67 (neutral) and its Stochastic is 67 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
RNR PE vs Financial Services Sector
| Metric | RNR | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 21% below |
| PE % | 62 | 63 | 1 pt below |
RNR has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
RNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $340.9 | 4% above |
| 20 week MA | $331.1 | 7.1% above |
| 50 week MA | $307.5 | 15% above |
| 100 week MA | $276.5 | 28% above |
| 200 week MA | $248.0 | 43% above |
RNR has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
RNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $195.7 | $161.4 | -18% |
| 2021 | $161.4 | $167.7 | +3.9% |
| 2022 | $167.7 | $186.9 | +11% |
| 2023 | $186.9 | $196.0 | +4.9% |
| 2024 | $196.0 | $250.6 | +28% |
| 2025 | $250.6 | $281.4 | +12% |
| 2026 YTD | $281.4 | $354.7 | +26% |
RNR has the edge over MS on returns for 2026, with the stronger performance.